Vidya Jaimungal
Family · Valrico, FLNPI 1821493891
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 88 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 14.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,510, more than ten times the $145 reported in 2022.
Across 88 payments — averaging $21.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$276
- Bayer$206
- AbbVie$172
- Lilly USA, LLC$116
- Exact Sciences$96
- Amgen$96
- plus $918 from 23 others
What the payments were for
- Food & beverage$1,880100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 13 | $276 |
| Bayer | 7 | $206 |
| AbbVie | 8 | $172 |
| Lilly USA, LLC | 6 | $116 |
| Exact Sciences | 4 | $96 |
| Amgen | 6 | $96 |
| Boston Scientific | 4 | $94 |
| Pfizer | 4 | $85 |
| Abbott | 4 | $76 |
| Astellas Pharma US Inc | 3 | $73 |
| GSK | 3 | $72 |
| Xeris Pharmaceuticals, Inc. | 3 | $64 |
| AstraZeneca | 4 | $62 |
| Hologic Sales And Service, LLC | 2 | $51 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $43 |
| Shield Therapeutics Inc | 2 | $34 |
| Organon | 1 | $31 |
| GRT US Holding, Inc. | 1 | $23 |
| Neuronetics, Inc. | 1 | $23 |
| Merck | 1 | $21 |
| Dexcom, Inc. | 1 | $21 |
| Phathom Pharmaceuticals, Inc. | 1 | $20 |
| Esperion Therapeutics, Inc. | 1 | $20 |
| Corcept Therapeutics | 1 | $19 |
| Bioventus LLC | 1 | $19 |
| SPR Therapeutics, Inc | 1 | $18 |
| Collegium Pharmaceutical, Inc. | 1 | $18 |
| Protega Pharmaceutials Inc | 1 | $17 |
| Medtronic | 1 | $15 |
How this compares
$1,880 in reported general payments places this provider in the 80th percentile of 14,618 family providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 24 | $975 |
| Doxycycline Monohydrate | 50 | $878 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 41 | $792 |
| Levothyroxine Sodium | 30 | $423 |
| Atorvastatin Calcium | 64 | $400 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 32 | $393 |
| Metoprolol Tartrate | 26 | $329 |
| Pantoprazole Sodium | 17 | $311 |
| Losartan Potassium | 30 | $298 |
| Baclofen | 14 | $206 |
| Metformin Hcl | 26 | $206 |
| Metoprolol Succinate | 21 | $195 |
| Methylprednisolone | 25 | $190 |
| Fluticasone Propionate | 25 | $190 |
| Amlodipine Besylate | 36 | $161 |
Paid to pharmacies, not to this prescriber.
Other family in Valrico
- Lewis HarringtonTampa$954K
- Danielle PharesFt Lauderdale$713K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
- Deena RodneyMaitland$323K
- Yamila MelendezMiami$212K
- Holly BoydLand O Lakes$200K
- Rachael BuschLoxahatchee$189K
- Victor Tatis de la NuezMiramar$161K
- Ronda CrewsJax Bch$155K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.